Serotyping and analysis of produced pigments kinds by pseudomonas aeruginosa clinical isolates;Serotipizacija i analiza vrsta proizvedenih pigmenata kliničd;kih izolata Pseudomonas aeruginosa

Vojnosanitetski Pregled

Volumn 68, Issue 11, 2011, Pages 923-929

  Nedeljkoví, Nataša Stanković ^a   Kocić, Branislava ^a   Tiodorović, Branislav ^a   Branković, Srbobran ^b   Antić, Snežana Mladenović ^c  

^a Higijensko epidemiološka služba ^*  (Serbia)

^b Klinicki centar Nis   (Serbia)

^c Institut za javno zdravlje   (Serbia)

Author keywords

Cross infection; Pseudomonas aeruginosa; Serotyping

Indexed keywords

FLUORESCEIN; PIGMENT; PYOCIN;

AGGLUTINATION TEST; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CROSS INFECTION; ENZYME SYNTHESIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEROTYPE; SEROTYPING;

FLUORESCEIN; PSEUDOMONAS AERUGINOSA; PYOCYANINE; SEROTYPING;

EID: 80955125560     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1111923S     Document Type: Article

References (41)

1. Severino P, Magalhães VD. The role of integrons in the dissemination of antibiotic resistance among clinical isolates of Pseudomonas aeruginosa from an intensive care unit in Brazil. Res Microbiol 2002; 153(4): 221-6.
2. Loughlin MF, Jones MV, Lambert PA. Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics. J Antimicrob Chemother 2002; 49(4): 631-9.
3. Li L, Ledizet M, Kar K, Koski RA, Kazmierczak BI. An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates. Ann Clin Microbiol Antimicrob 2005; 4: 22.
4. Worgall S, Krause A, Qiu J, Joh J, Hackett NR, Crystal RG. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF. J Virol 2007; 81(24): 13801-8.
5. Komiyama K, Habbick BF, Martin T, Tumber SK. Characterization by pyocine typing and serotyping of oral and sputum strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Can J Microbiol 1987; 33(3): 221-5.
6. Loureiro MM, de Moraes BA, Mendonca VL, Quadra MR, Pinheiro GS, Asensi MD. Pseudomonas aeruginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janeiro City, Brazil. Mem Inst Oswaldo Cruz 2002; 97(3): 387-94.
7. Albrecht MT, Wang W, Shamova O, Lehrer RI, Schiller NL. Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia. Respir Res 2002; 3: 18.
8. Estahbanati HK, Kashani PP, Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 2002; 28(4): 340-8.
9. Englender M, Harell M, Guttman R, Segal S. Typing of Pseudomonas aeruginosa ear infections related to outcome of treatment. J Laryngol Otol 1990; 104(9): 678-81.
10. Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 2009; 58(Pt 4): 492-502.
11. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. Ironbinding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 2009; 58(Pt 6): 765-73.
12. Ninane G, Harper PB. The in vitro activity of ceftazidime against a multi-resistant serotype 12 Pseudomonas aeruginosa. Infection 1983; 11 Suppl 1: S16-9.
13. Jamasbi JR. Frequency and distribution of Pseudomonas aeruginosa serotypes O:3, O:6, O:11 in three northwestern Ohio hospitals as determined by ELISA using specific monoclonal antibodies. Ohio J Sci 1999; 99(2): 10-5.
14. Al-Dujaili HA, Harris DM. Evaluation of commercially available antisera for erotyping of Pseudomonas aeruginosa. J. Clin. Path 1974; 27(7): 569-71.
15. van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, et al.Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13(Suppl 3): 1-46.
16. Perumal D, Lim CS, Chow VT, Sakharkar KR, Sakharkar MK. A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species. Int J Biol Sci 2008; 4(5): 309-17.
17. Faure K, Shimabukuro D, Ajayi T, Allmond LR, Sawa T, WienerKronish JP. O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J Clin Microbiol 2003; 41(5): 2158-60.
18. McLean MD, Almquist KC, Niu Y, Kimmel R, Lai Z, Schreiber JR, et al. A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrob Agents Chemother 2007; 51(9): 3322-8.
19. Kaluzny K, Abeyrathne PD, Lam JS. Coexistence of two distinct versions of O-antigen polymerase, Wzy-alpha and Wzy-beta, in Pseudomonas aeruginosa serogroup O2 and their contributions to cell surface diversity. J Bacteriol 2007; 189(11): 4141-52.
20. Grothues D, Koopmann U, von der Hardt H, Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988; 26(10): 1973-7.
21. Elaichouni A, Verschraegen G, Claeys G, Devleeschouwer M, Godard C, Vaneechoutte M. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol 1994; 32(3): 666-71.
22. Raymond CK, Sims EH, Kas A, Spencer DH, Kutyavin TV, Ivey RG, et al. Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J Bacteriol 2002; 184(13): 3614-22.
23. Currie HL, Lightfoot J, Lam JS. Prevalence of gca, a gene involved in synthesis of A-band common antigen polysaccharide in Pseudomonas aeruginosa. Clin Diagn Lab Immunol 1995; 2(5): 554-62.
24. Soler CP, Gidenne S, Saint-Blancard P, Kerleguer A, Gerome P. Recovery method of serotypable character in non serotypable pseudomonas aeruginosa strains. Pathol Biol (Paris) 2004; 52(1): 33-8. (French)
25. Zierdt CH, Williams RL. Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol 1975; 1(6): 521-6.
26. Mutharia LM, Nicas TI, Hancock RE. Outer membrane proteins of Pseudomonas aeruginosa serotype strains. J Infect Dis 1982; 146(6): 770-9.
27. Goto S, Tsuji A, Oguri T, Kobayashi I, Nishida M, Yabuuchi E. Present situation of serotyping of Pseudomonas aeruginosa in Japan and correlation among three kinds of commercially available serotyping kits. J Infect Chemother 1999; 5(4): 201-5.
28. Lamont IL, Martin LW. Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa. Microbiology 2003; 149(Pt 4): 833-42.
29. Karakašević B. Manual on standard wethards for microbiological routine experiments. Beograd-Zagreb: Medicinska knjiga; 1967. (Serbian)
30. Kumar A, Gao N, Standiford TJ, Gallo RL, Yu FS. Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection. Microbes Infect 2010; 12(12-13): 978-89.
31. Shupp JW, Pavlovich AR, Jeng JC, Pezzullo JC, Oetgen WJ, Jaskille AD, et al. Epidemiology of bloodstream infections in burninjured patients: a review of the national burn repository. J Burn Care Res 2010; 31(4): 521-8.
32. Tomanović B, Joković B, Tatić M, Mirovič V, Nanusević O. Serotyping and pyocin typing of Pseudomonas aeruginosa in a study of intrahospital infections. Vojnosanit Pregl 1991; 48(1): 31-3. (Serbian)
33. Thuruthyil SJ, Zhu H, Willcox MD. Serotype and adhesion of Pseudomonas aeruginosa isolated from contact lens wearers. Clin Experiment Ophthalmol 2001; 29(3): 147-9.
34. de Vicente A, Codina JC, Martinez-Manzanares E, Aviles M, Borrego JJ, Romero P. Serotypes and pyocin types of Pseudomonas aeruginosa isolated from natural waters. Lett Appl Microbiol 1990; 10(2): 77-80.
35. Burke V, Richardson CJ, Robinson J. Serotype and serum sensitivity of Pseudomonas aeruginosa from children with cystic fibrosis: longitudinal studies and typing with monoclonal antibodies. Pathology 1990; 22(4): 223-6.
36. Millesimo M. de Intinis G. Chirillo M. G. MussotT. Savoila D. Pseudomonas aeruginosa clinical isolates: Serotypes, resistance phenotypes and plasmid profiles. European journal of epidemiology 1996; Vol. 12, No2: 123-130
37. Tsakris A, Pournaras S, Woodford N, Palepou MF, Babini GS, Dauboyas J, et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 2000; 38(3): 1290-2.
38. Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, et al. Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J Med Microbiol 2008; 57(Pt 12): 1454-65.
39. Jamasbi JR, Proudfoot ME. Phenotypic and genotypic characteristics of clinical isolates of Pseudomonas aeruginosa: Rate of occurrence and distribution of different serotypes antimicrobial susceptibility profiles and molecular typing. Lab Med. 2008; 39(3): 155-61.
40. Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA. Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol 2005; 54(Pt 6): 519-26.
41. Mittal R, Khandwaha RK, Gupta V, Mittal PK, Harjai K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa & their association with mouse renal colonization. Indian J Med Res 2006; 123(1): 67-72.